skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,862  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cancer‐specific risk prediction with a serum microRNA signature
Material Type:
Article
Add to My Research

Cancer‐specific risk prediction with a serum microRNA signature

Cancer science, 2024-06, Vol.115 (6), p.2049-2058 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16135 ;PMID: 38523358

Full text available

2
Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan‐cancer
Material Type:
Article
Add to My Research

Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan‐cancer

Cancer science, 2024-06, Vol.115 (6), p.1820-1833 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16168 ;PMID: 38571294

Full text available

3
Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J‐SUPPORT 2001 Study)
Material Type:
Article
Add to My Research

Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J‐SUPPORT 2001 Study)

Psychiatry and clinical neurosciences, 2024-06, Vol.78 (6), p.353-361 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13657 ;PMID: 38468404

Full text available

4
FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma
Material Type:
Article
Add to My Research

FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma

Cancer science, 2024-06, Vol.115 (6), p.1896-1909 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16140 ;PMID: 38480477

Full text available

5
Autologous HSCT with novel agent‐based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma
Material Type:
Article
Add to My Research

Autologous HSCT with novel agent‐based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma

Cancer science, 2024-06, Vol.115 (6), p.2002-2011 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16158 ;PMID: 38498976

Full text available

6
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments
Material Type:
Article
Add to My Research

Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments

Cancer science, 2024-06, Vol.115 (6), p.1763-1777 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16154 ;PMID: 38527308

Full text available

7
Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer
Material Type:
Article
Add to My Research

Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer

Cancer science, 2024-06, Vol.115 (6), p.1866-1880 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16129 ;PMID: 38494600

Full text available

8
Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer
Material Type:
Article
Add to My Research

Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer

Cancer science, 2024-06, Vol.115 (6), p.1989-2001 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16149 ;PMID: 38531808

Full text available

9
A new tandem repeat‐enriched lncRNA XLOC_008672 promotes gastric carcinogenesis by regulating G3BP1 expression
Material Type:
Article
Add to My Research

A new tandem repeat‐enriched lncRNA XLOC_008672 promotes gastric carcinogenesis by regulating G3BP1 expression

Cancer science, 2024-06, Vol.115 (6), p.1851-1865 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16172 ;PMID: 38581120

Full text available

10
Antiapoptotic PON2 expression and its clinical implications in locally advanced oral squamous cell carcinoma
Material Type:
Article
Add to My Research

Antiapoptotic PON2 expression and its clinical implications in locally advanced oral squamous cell carcinoma

Cancer science, 2024-06, Vol.115 (6), p.2012-2022 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16170 ;PMID: 38602182

Full text available

11
Plasma biomarkers for predicting the development of dementia in a community‐dwelling older Japanese population
Material Type:
Article
Add to My Research

Plasma biomarkers for predicting the development of dementia in a community‐dwelling older Japanese population

Psychiatry and clinical neurosciences, 2024-06, Vol.78 (6), p.362-371 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13661 ;PMID: 38606661

Full text available

12
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma
Material Type:
Article
Add to My Research

MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma

Cancer science, 2024-06, Vol.115 (6), p.1791-1807 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16151 ;PMID: 38480904

Full text available

13
ECM1 and KRT6A are involved in tumor progression and chemoresistance in the effect of dexamethasone on pancreatic cancer
Material Type:
Article
Add to My Research

ECM1 and KRT6A are involved in tumor progression and chemoresistance in the effect of dexamethasone on pancreatic cancer

Cancer science, 2024-06, Vol.115 (6), p.1948-1963 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16175 ;PMID: 38613239

Full text available

14
Decreased risk of renal cell carcinoma in patients with type 2 diabetes treated with sodium glucose cotransporter‐2 inhibitors
Material Type:
Article
Add to My Research

Decreased risk of renal cell carcinoma in patients with type 2 diabetes treated with sodium glucose cotransporter‐2 inhibitors

Cancer science, 2024-06, Vol.115 (6), p.2059-2066 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16157 ;PMID: 38572526

Full text available

15
Unraveling the gut‐brain connection: The association of microbiota‐linked structural brain biomarkers with behavior and mental health
Material Type:
Article
Add to My Research

Unraveling the gut‐brain connection: The association of microbiota‐linked structural brain biomarkers with behavior and mental health

Psychiatry and clinical neurosciences, 2024-06, Vol.78 (6), p.339-346 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13655 ;PMID: 38421082

Full text available

16
An unwelcome side‐effect of trazodone use in a trans‐male
Material Type:
Article
Add to My Research

An unwelcome side‐effect of trazodone use in a trans‐male

Psychiatry and clinical neurosciences, 2024-06, Vol.78 (6), p.376-376 [Peer Reviewed Journal]

2024 The Authors. Psychiatry and Clinical Neurosciences © 2024 Japanese Society of Psychiatry and Neurology. ;2024 Japanese Society of Psychiatry and Neurology ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13665 ;PMID: 38506036

Full text available

17
A case of bipolar I disorder with a loss‐of‐function variant of schizophrenia risk gene SETD1A: possible expansion of the relevant clinical spectrum supported by a meta‐analysis
Material Type:
Article
Add to My Research

A case of bipolar I disorder with a loss‐of‐function variant of schizophrenia risk gene SETD1A: possible expansion of the relevant clinical spectrum supported by a meta‐analysis

Psychiatry and clinical neurosciences, 2024-06, Vol.78 (6), p.374-375 [Peer Reviewed Journal]

2024 The Authors. Psychiatry and Clinical Neurosciences © 2024 Japanese Society of Psychiatry and Neurology. ;2024 Japanese Society of Psychiatry and Neurology ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13669 ;PMID: 38646907

Full text available

18
Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer
Material Type:
Article
Add to My Research

Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer

Cancer science, 2024-06, Vol.115 (6), p.1979-1988 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16142 ;PMID: 38487949

Full text available

19
Identification of barriers to implementation of precision oncology in patients with rare cancers
Material Type:
Article
Add to My Research

Identification of barriers to implementation of precision oncology in patients with rare cancers

Cancer science, 2024-06, Vol.115 (6), p.2023-2035 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16165 ;PMID: 38538548

Full text available

20
ILT4 facilitates angiogenesis in non-small cell lung cancer
Material Type:
Article
Add to My Research

ILT4 facilitates angiogenesis in non-small cell lung cancer

Cancer science, 2024-05, Vol.115 (5), p.1459-1475 [Peer Reviewed Journal]

2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16126 ;PMID: 38433526

Full text available

Results 1 - 20 of 6,862  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1983  (156)
  2. 1983 To 1992  (647)
  3. 1993 To 2002  (1,857)
  4. 2003 To 2013  (2,514)
  5. After 2013  (1,689)
  6. More options open sub menu

Subject 

  1. Male  (6,841)
  2. Life Sciences & Biomedicine  (6,400)
  3. Science & Technology  (6,400)
  4. Humans  (5,384)
  5. Female  (4,744)
  6. Biological And Medical Sciences  (3,476)
  7. Oncology  (3,157)
  8. Medical Sciences  (3,153)
  9. Middle Aged  (3,125)
  10. Adult  (2,987)
  11. Aged  (2,394)
  12. Animals  (2,245)
  13. Psychiatry  (2,173)
  14. Neurosciences  (2,170)
  15. Neurosciences & Neurology  (2,170)
  16. Clinical Neurology  (2,113)
  17. Tumors  (1,924)
  18. General Medicine  (1,491)
  19. Cancer Research  (1,309)
  20. Original  (1,282)
  21. More options open sub menu

Language 

  1. Japanese  (2,363)
  2. Swedish  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait